kabutan

KAKEN PHARMA, Returning to Profitability This Year

Wed May 13, 2026 3:30 pm JST Earnings

4521 KAKEN PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KAKEN PHARMACEUTICAL CO.,LTD. <4521> [TSE Prime] announced its financial results after the market closed on May 13th (15:30). The consolidated ordinary profit/loss for the fiscal year ended March 2026 turned into a loss of 0.20 billion yen (compared to a profit of 21.2 billion yen in the previous period). For the fiscal year ending March 2027, the consolidated ordinary profit/loss is expected to recover to profit of 8.60 billion yen.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary loss improved to a deficit of 1.37 billion yen (compared to a loss of 4.80 billion yen in the same period last year). The operating profit/loss margin drastically improved from -24.3% in the same period last year to -7.5%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 72,044 9,513 9,951 8,025 212.7 150 May 14, 2024 J-GAAP
Mar, 2025 94,035 21,034 21,279 13,945 365.4 190 May 12, 2025 J-GAAP
Mar, 2026 76,871 -899 -206 2,144 56.6 190 May 13, 2026 J-GAAP
YoY -18.3% － － -84.6% -84.5%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Guidance 76,900 -900 -200 2,100 55.4 190 Apr 22, 2026 J-GAAP
Mar, 2026 Results 76,871 -899 -206 2,144 56.6 190 May 13, 2026 J-GAAP
Revision Rate 0.0% +0.1% -3.0% +2.1% +2.1%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 39,356 203 607 992 26.2 95 Nov 10, 2025 J-GAAP
Apr - Sep, 2026 Guidance ー ー ー ー － 95 May 13, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 94,035 21,034 21,279 13,945 365.4 190 May 12, 2025 J-GAAP
Mar, 2026 76,871 -899 -206 2,144 56.6 190 May 13, 2026 J-GAAP
Mar, 2027 Guidance 89,900 7,900 8,600 6,500 171.7 190 May 13, 2026 J-GAAP
YoY +16.9% － － +203.2% +203.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 18,045 -4,386 -4,802 -5,230 -137.1 -24.3 May 12, 2025 J-GAAP
Apr - Jun, 2025 18,867 14 417 271 7.1 0.1 Aug 7, 2025 J-GAAP
Jul - Sep, 2025 20,489 189 190 721 19.0 0.9 Nov 10, 2025 J-GAAP
Oct - Dec, 2025 18,261 351 565 406 10.7 1.9 Feb 6, 2026 J-GAAP
Jan - Mar, 2026 19,254 -1,453 -1,378 746 19.7 -7.5 May 13, 2026 J-GAAP
YoY +6.7% +66.9% +71.3% － －

Related Articles